Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE  
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel,   BELGIË  
 
Tel: +32 229 -91111. Fax: +32 229- 64301. E -mail: COMP -MERGER -REGISTRY@ec.europa.eu.  
  EUROPEAN COMMISSION  
Brussels, 27.9.2021  
C(2021)  7102 final  
PUBLIC VERSION 
Canada Pension Plan Investment 
Board   
One Queen Street East, Suite 2500  
Toronto, ON M5C 2W5 
Canada  
 
FountainVest Capital Partners GP4 
Ltd. 
c/o Intertrust Corporate Services (Cayman) Limited   
One Nexus way, Camana Bay  
Grand Cayman, KY1 -9005  
Cayman Islands  
Subject : Case M. 10452  – CPP INVESTMENTS / FOUNTAINVEST / LANGDI 
PHARMACEUTICAL  
Commission decision pursuant to Article 6(1)(b) of Council Regulation 
(EC) No 139/20041 and Article 57 of the Agreement on the European 
Economic Area2  
Dear Sir or Madam,  
1. On 2 September 2021, the European Commission received notification of a proposed 
concentration pursuant to Article 4 of the Merger  Regulation by which Canada 
Pension Plan Invest ment Board (“CPP Investments”, Canada)  and FountainVest 
Capital Partners GP4 Ltd.  (“FountainVest”, Cayman Islands ) acquire within the 
meaning of Article 3(1)(b) of the Merger Regulation joint control of Beijing 
Zhendong Langdi Pharmaceutical Co., Ltd. and its subsidiaries (“Langdi 
Pharmaceutical”, China)  by way of purchase of shares .3 
                                                
1 OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation ’). With effect from 1 December 2009,  the Treaty on 
the Functioning of the European Union ( ‘TFEU ’) has introduc ed certain changes, such as the 
replacement of ‘Community ’ by ‘Union ’ and ‘common market ’ by ‘internal market ’. The terminology 
of the TFEU will be used throughout this decision.  
2  OJ L 1, 3.1.1994, p.  3 (the ‘EEA Agreement ’). 
3  Publication in the Official Journal of the European Union No C 365, 10.9.2021 , p. 5. 

2 2. The business activities of the undertakings concerned are:  
− CPP Investments is a professional investment management organisation that 
invests in public equities, private equiti es, real estate, infrastructure and fixed 
income instruments.  
− FountainVest is an independent private equity firm. Sectors of focus include consumer, media & technology, healthcare, industrials, and financial services.  
− Langdi Pharmaceutical is a pharmaceuti cal company mainly active in the 
production and supply of calcium supplements for children, pregnant and lactating women, menopausal women and elderly people, to help prevent and 
treat osteoporosis, which are registered as over -the-counter (OTC) products.  
3. After examination of the notification, the European Commission has concluded that 
the notified operation falls within the scope of the Merger  Regulation  and of 
paragraph 5 (a) of the Commission Notice on a simplified procedure for treatment of 
certain conce ntrations under Council Regulation (EC) No  139/2004.
4 
4. For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it 
compatible with the internal market and with the EEA Agreement. This decision is 
adopted in application of Article 6(1)(b) of the Merger  Regulation  and Article 57 of 
the EEA Agreement . 
For the Commission  
 
 
(Signed)  
Olivier GUERSENT  
Director -General  
                                                
4  OJ C 366, 14.12.2013, p. 5 .